Impact of the recurrence score (RS) result and mismatch repair status (MMR) on agreement between oncologists (MDs) for stage II colon cancer (CC) recurrence risk (RR) assessment: A novel clinical utility endpoint for prognostic markers.
Robin Katie Kelley
Consultant or Advisory Role - Genomic Health (U)
Research Funding - Genomic Health
Margarita Lopatin
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Jimmy Hwang
No relevant relationships to disclose
Michael Crager
Employment or Leadership Position - Genomic Health
Adrienne A Brenner
No relevant relationships to disclose
Jane Kuczma
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Ashley King
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Calvin Chao
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Mark Lee
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Alan Paul Venook
Research Funding - Genomic Health